Further, constituents of Ad-vector COVID-19 vaccines may play the role of “co-factor” binding to PF4, inducing newly formed immunogenic epitopes that potentially induce the production of the pathological anti-PF4 immunoglobulins. The gene discussed is PF4; the disease is COVID-19.